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Assessment of sputum cultures for the 
diagnosis of lower-respiratory tract 
infections in the outpatient setting
To the Editor: The clinical relevance of lower-respiratory tract 
(LRT) specimens remains debatable. While a positive blood or 
pleural fluid culture provides a definitive cause, an organism 
cultured from a respiratory specimen is not definitive proof of 
an aetiological agent. Many bacterial species are normal flora or 
colonisers of the respiratory tract; therefore, routine use of sputum 
cultures, except for suspected Mycobacterium tuberculosis (TB), is 
not endorsed. Notably, the South African (SA) guideline for the 
management of community-acquired pneumonia (CAP) in adults 
and the American Thoracic Society/Infectious Diseases Society of 
America do not recommend the submission of a sputum sample in 
outpatients.[1,2] 
The objective of this study was: (i) to determine the yield of 
positive cultures from sputum collected in the outpatient setting 
in the Cape Town metropole; and (ii) to establish the prevalence 
of recognised pathogens and corresponding antibiograms. In our 
laboratory survey, sputum cultures were analysed retrospectively 
over 1 year from samples collected in the outpatient setting and 
submitted to the National Health Laboratory Service (NHLS), 
Groote Schuur Hospital (GSH), during 2018 (Fig.1). Patients with 
underlying lung disease caused by cystic fibrosis, and patients from 
respiratory clinics, were excluded. 
A pathogen was identified in only 174 of 2 262 (7.7%) sputum 
cultures, while 2 088 cultures were reported as mixed growth or 
normal respiratory flora. Fifty-two percent (n=92/174) of specimens 
with a pathogen organism yielded Haemophilus influenzae, 12% 
(n=26/174) Moraxella catarrhalis and 9% (n=12/174) Streptococcus 
pneumoniae. These bacteria represent the common causes of CAP 
in adults and children between 2 months and 5 years of age in 
SA.[1,3] From the 174 cultures, only 5% (n=9) were from child ren 
≤5 years old. Ninety-nine percent (n=90/91) of H. influenzae were 
susceptible to co-amoxiclav, 97% (n=87/91) to amoxicillin and 
100% to ceftriaxone, while 48% (n=44/91) were resistant to co- 
trimoxazole. Only 2 of 16 S. pneumoniae isolates were not suscep-
tible to penicillin.
Numerous factors contribute to the low yield of pathogens 
cultured from sputum samples in the outpatient setting. These 
include patients with a low positive predictive value, given their 
symptoms and signs, and the likelihood of a viral infection, poor-
quality samples collected with saliva and delayed transport from 
the healthcare facility to the laboratory, resulting in overgrowth 
of respiratory flora.[4,5] Non-significant cultures do not only affect 
patient management, but also increase the need for additional 
laboratory staff and healthcare workers to process and collect 
samples. This situation also ultimately has financial implications. 
The laboratory survey had the following limitations. It did 
not include clinical epidemiology, such as patient comorbidities, 
presence of structural lung diseases (e.g. acute exacerbations in 
chronic bronchitis), co-infection with TB or molecular diagnostics. 
We also did not investigate the diagnostic value of sputum-quality 
assessment. Data were obtained from community healthcare centres 
serviced by the NHLS at GSH. Furthermore, the retrospective 
nature of this study relied on the integrity of data extracted from 
the laboratory information system.
In conclusion, the diagnostic yield of sputum samples collected in 
the outpatient setting remains very low, with only 7.7% of cultures 
in this laboratory survey growing a recognised bacterial pathogen. 
The interpretation of sputum cultures continues to be a challenge for 
microbiology laboratories and the value of obtaining LRT samples is 
questionable. 
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Fig. 1. Sputum cultures from suspected community-acquired pneumonia 
outpatients in 2018, submitted to the National Health Laboratory Service, 
Groote Schuur Hospital, South Africa. (Respiratory flora = normal 
nasopharynx-colonising flora; mixed growth = no predominance of Gram-
negative or Gram-positive bacteria among normal respiratory flora.) 
